Accéder au contenu
MilliporeSigma
Toutes les photos(1)

Key Documents

View All Documentation

47674

Sigma-Aldrich

Fmoc-Gln(Trt)-OH

≥98.0% (HPLC), for peptide synthesis

Synonyme(s) :

Nα-Fmoc-Nδ-trityl-L-glutamine

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C39H34N2O5
Numéro CAS:
132327-80-1
Poids moléculaire :
610.70
Numéro Beilstein :
4343953
Numéro MDL:
MFCD00077056
Code UNSPSC :
12352209
eCl@ss :
32160406
ID de substance PubChem :
57651077
Nomenclature NACRES :
NA.26

product name

Fmoc-Gln(Trt)-OH, ≥98.0% (HPLC)

Niveau de qualité

100

Pureté

≥98.0% (HPLC)

Forme

powder

Activité optique

[α]/D -14.0±1.5°, c = 1% in DMF

Capacité de réaction

reaction type: Fmoc solid-phase peptide synthesis

Application(s)

peptide synthesis

Groupe fonctionnel

Fmoc

Température de stockage

2-8°C

Chaîne SMILES 

OC(=O)[C@H](CCC(=O)NC(c1ccccc1)(c2ccccc2)c3ccccc3)NC(=O)OCC4c5ccccc5-c6ccccc46

InChI

1S/C39H34N2O5/c42-36(41-39(27-14-4-1-5-15-27,28-16-6-2-7-17-28)29-18-8-3-9-19-29)25-24-35(37(43)44)40-38(45)46-26-34-32-22-12-10-20-30(32)31-21-11-13-23-33(31)34/h1-23,34-35H,24-26H2,(H,40,45)(H,41,42)(H,43,44)/t35-/m0/s1

Clé InChI

WDGICUODAOGOMO-DHUJRADRSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Fmoc-Gln(Trt)-OH also known as Nα-Fmoc-Nδ-trityl-L-glutamine, a Fmoc protected amino acid derivative used as a reagent in the synthesis of peptides. As glutamine is protected with a trityl group, unwanted substitute products in the reactions can be prevented.

Application

Fmoc-Gln(Trt)-OH is used as a starting material in the Fmoc solid phase peptide synthesis of fellutamide B and N-octanoyl analog of fellutamide B.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Équipement de protection individuelle

Eyeshields, Gloves, type N95 (US)

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
BCCG2426
BCCF4932
BCCC8888
BCCB9522
BCBZ1861

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 5

1 of 5

Fmoc-Cys(Trt)-OH ≥95.0% (sum of enantiomers, HPLC)

Sigma-Aldrich

47695

Fmoc-Cys(Trt)-OH

Fmoc-Lys(Boc)-OH ≥98.0% (HPLC)

Sigma-Aldrich

47624

Fmoc-Lys(Boc)-OH

Boc-Gln(Trt)-OH Novabiochem®

Sigma-Aldrich

8.53075

Boc-Gln(Trt)-OH

Fmoc-Phe-OH 98%

Sigma-Aldrich

338338

Fmoc-Phe-OH

Boc-Gln(Trt)-OH ≥98.0% (TLC)

Sigma-Aldrich

15563

Boc-Gln(Trt)-OH

Cathleen Jendrny et al.
Chembiochem : a European journal of chemical biology, 17(8), 719-726 (2015-11-18)
Serpin proteins irreversibly inhibit serine proteases, but only a small part of the serpin reactive-center loop (RCL) is responsible for the initial protein-protein interaction (PPI). To develop peptidic protease inhibitors, kallikrein-related peptidases 7 (KLK7) and 5 (KLK5) were chosen. Firstly
Marcus Pickhardt et al.
Current Alzheimer research, 14(7), 742-752 (2017-02-06)
Anti-aggregation drugs play an important role in therapeutic approaches for Alzheimer's disease. We have previously developed a number of compounds that are able to inhibit the pathological aggregation of Tau protein. One common obstacle to application is the limited penetration
Fatemeh Zabihi et al.
Journal of controlled release : official journal of the Controlled Release Society, 242, 35-41 (2016-07-30)
Nanogels offer many unique features rendering them as very attractive candidates for drug delivery. However, for their applications the loading capacity and specific encapsulation, in particular for hydrophobic drugs, in a complex media are two critical factors. In this work
Hong Cheng et al.
Macromolecular bioscience, 19(4), e1800410-e1800410 (2018-12-24)
In this paper, a self-delivery chimeric peptide PpIX-PEG8 -KVPRNQDWL is designed for photodynamic therapy (PDT) amplified immunotherapy against malignant melanoma. After self-assembly into nanoparticles (designated as PPMA), this self-delivery system shows high drug loading rate, good dispersion, and stability as
Zdenek Kukacka et al.
ChemMedChem, 13(9), 909-915 (2018-02-24)
α-Galactosidase (αGal) is a lysosomal enzyme that hydrolyses the terminal α-galactosyl moiety from glycosphingolipids. Mutations in the encoding genes for αGal lead to defective or misfolded enzyme, which results in substrate accumulation and subsequent organ dysfunction. The metabolic disease caused
Afficher tous les articles scientifiques apparentés

Articles

Natural Amino Acid Building Blocks for Peptide Synthesis

With a growing peptide drug market the fast, reliable and uncomplicated synthesis of peptides is of paramount importance.

Natural Amino Acid Building Blocks for Peptide Synthesis

With a growing peptide drug market the fast, reliable and uncomplicated synthesis of peptides is of paramount importance.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique